should i switch from semaglutide to tirzepatide Weight-loss injections such as GLP-1 agonists (including and tirzepatide) are increasingly used — but they can affect how some oral medications are absorbed, including contraception and Hormone Replacement Therapy (HRT) New Switching from Semaglutide to Tirzepatide:

(Source: Applied Clinical Trials, 2026) Weight Loss Progress Over Time STEP-1 Trial Related at GoalBMI Wellness Semaglutide & Cardiovascular Health SELECT Trial Data Beyond weight loss, the 2023 SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial established semaglutide as a cardiovascular medication a landmark finding that expanded its clinical use far beyond obesity treatment

The medications work through different mechanisms, produce different magnitudes of effect, and follow different dose escalation curves

Tapering semaglutide to the most effective dose: real-world evidence from a digital weight management programme (TAILGATE) by Sren Seier, Kine Stamp Larsen, Jesper Pedersen, Jorne Biccler and Henrik Gudbergsen, April 2024, European Congress on Obesity (ECO2024)

Mito: "Puedo comprarla sin receta" Verdad: Es un medicamento de prescripcin mdica retenida

Hormonal imbalances can trigger weight gain or resistance to weight loss, while excess weight can disrupt hormone levels, potentially leading to hormone imbalance and metabolic disorders

Structure of PEG Loxenatide Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates both the GLP-1 and GIP signaling pathways